Sogulasvhili T, Gamkrelidze N, Pavliashvili N, Kvatchadze L, Katsadze M. Colchicine Plus Rosuvastatin/Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities. GBMN [Internet]. 2026 Jul. 24 [cited 2026 Nov. 5];4(3):177-86. Available from: https://gbmn.org/article/view/365